Theranostics

In a special presentation on April, Dr. Jeremie Calais presented a comprehensive update on research and clinical trials for PSMA targeted theranostics (combination of therapeutic and diagnostic approaches) for prostate cancer. You'll find the recording, with a summary, on the Presentations page.